DE GIORGI, UGO FEDERICO FRANCESCO
DE GIORGI, UGO FEDERICO FRANCESCO
DIPARTIMENTO DI MEDICINA SPERIMENTALE
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases
2010-01-01 De Giorgi, U; Mego, M; Rohren, E; Liu, P; Handy, Bc; Reuben, Jm; Macapinlac, Ha; Hortobagyi, Gn; Cristofanilli, M; Ueno, Nt.
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
2015-01-01 De Giorgi, U; Caroli, P; Scarpi, E; Conteduca, V; Burgio, Sl; Menna, C; Moretti, A; Galassi, R; Rossi, L; Amadori, D; Paganelli, G; Matteucci, F
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
2015-01-01 DE GIORGI, Ugo; Caroli, Paola; Scarpi, Emanuela; Conteduca, Vincenza; Burgio, Salvatore Luca; Menna, Cecilia; Moretti, Andrea; Galassi, Riccardo; Rossi, Lorena; Amadori, Dino; Paganelli, Giovanni; Matteucci, Federica
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
2018-01-01 Caroli, Paola; Sandler, Israel; Matteucci, Federica; de Giorgi, Ugo; Uccelli, Licia; Celli, Monica; Foca, Flavia; Barone, Domenico; Romeo, Antonino; Sarnelli, Anna; Paganelli, Giovanni
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer
2018-01-01 Malaspina, Simona; De Giorgi, Ugo; Kemppainen, Jukka; Del Sole, Angelo; Paganelli, Giovanni
[177 Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?
2018-01-01 Paganelli, Giovanni; De Giorgi, Ugo
[18F]fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy.
2010-01-01 De Giorgi, U; Amadori, D.
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity
2001-01-01 Bacci, G; Ferrari, S; Tienghi, A; Bertoni, F; Mercuri, M; Longhi, A; Fiorentini, G; Forni, C; Bacchini, P; Rimondini, S; De Giorgi, U; Picci, P
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma
2020-01-01 Lolli, C.; Altavilla, A.; Conteduca, V.; Farolfi, A.; Casadei, C.; Schepisi, G.; Banna, G. L.; De Giorgi, U.
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group
2022-01-01 Bartoletti, M.; Bergamini, A.; Giannone, G.; Nero, C.; Musacchio, L.; Farolfi, A.; Passarelli, A.; Kuhn, E.; Castaldo, D.; Lombardo, V.; Di Palma, T.; Lorusso, D.; Puglisi, F.; De Giorgi, U.; Valabrega, G.; Schettino, C.; Scambia, G.; Capoluongo, E.; Pignata, S.
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients
2012-01-01 Eechoute, K; Fransson, Mn; Reyners, Ak; de Jong, Fa; Sparreboom, A; van der Graaf, Wt; Friberg, Le; Schiavon, G; Wiemer, Ea; Verweij, J; Loos, Wj; Mathijssen, Rh; De Giorgi, U
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer
2015-01-01 Pietri, E; Andreis, D; Fabbri, F; Menna, C; Schirone, A; Kopf, B; Rocca, A; Amadori, D; De Giorgi, U
A Phase II study of everolimus plus oral prednisone in patients with metastatic renal cell cancer
2017-01-01 Lolli, C; Gallà, V; Schepisi, G; Barone, D; Luca Burgio, S; Maugeri, A; Vertogen, B; Amadori, D; De Giorgi, U
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization
2006-01-01 Kopf, B; De Giorgi, U; Vertogen, B; Monti, G; Molinari, A; Turci, D; Dazzi, C; Leoni, M; Tienghi, A; Cariello, A; Argnani, M; Frassineti, L; Scarpi, E; Rosti, G; Marangolo, M.
A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study
2000-01-01 Dazzi, C; Cariello, A; Giannini, M; Del Duca, M; Giovanis, P; Fiorentini, G; Leoni, M; Rosti, G; Turci, D; Tienghi, A; Vertogen, B; Zumaglini, F; De Giorgi, U; Marangolo, M
Addition of androgen receptor targeted agents to androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
2022-01-01 Maiorano, B. A.; De Giorgi, U.; Roviello, G.; Messina, C.; Altavilla, A.; Cattrini, C.; Mennitto, A.; Maiello, E.; Di Maio, M.
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey
2016-01-01 Diminutto, A; Basso, U; Maruzzo, M; Morelli, F; De Giorgi, U; Perin, A; Fraccon, Ap; Lo Re, G; Rizzi, A; Sava, T; Fornarini, G; Valcamonico, F; Zustovich, F; Massari, F; Zanardi, E; Roma, A; Zattoni, F; Zagonel, V
Adjuvant concomitant chemotherapy in pancreatic cancer.
1999-01-01 Turci, D; Cariello, A; De Giorgi, U
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: Results from the Italian national registry
2014-01-01 Pedrazzoli, P; Martinelli, G; Gianni, Am; Da Prada, Ga; Ballestrero, A; Rosti, G; Frassineti, Gl; Aieta, M; Secondino, S; Cinieri, S; Fedele, R; Bengala, C; Bregni, M; Grasso, D; De Giorgi, U; Lanza, F; Castagna, L; Bruno, B; Martino, M
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry
2014-01-01 Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ballestrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases | 1-gen-2010 | De Giorgi, U; Mego, M; Rohren, E; Liu, P; Handy, Bc; Reuben, Jm; Macapinlac, Ha; Hortobagyi, Gn; Cristofanilli, M; Ueno, Nt. | |
| 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide | 1-gen-2015 | De Giorgi, U; Caroli, P; Scarpi, E; Conteduca, V; Burgio, Sl; Menna, C; Moretti, A; Galassi, R; Rossi, L; Amadori, D; Paganelli, G; Matteucci, F | |
| 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide | 1-gen-2015 | DE GIORGI, Ugo; Caroli, Paola; Scarpi, Emanuela; Conteduca, Vincenza; Burgio, Salvatore Luca; Menna, Cecilia; Moretti, Andrea; Galassi, Riccardo; Rossi, Lorena; Amadori, Dino; Paganelli, Giovanni; Matteucci, Federica | |
| 68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients | 1-gen-2018 | Caroli, Paola; Sandler, Israel; Matteucci, Federica; de Giorgi, Ugo; Uccelli, Licia; Celli, Monica; Foca, Flavia; Barone, Domenico; Romeo, Antonino; Sarnelli, Anna; Paganelli, Giovanni | |
| 68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer | 1-gen-2018 | Malaspina, Simona; De Giorgi, Ugo; Kemppainen, Jukka; Del Sole, Angelo; Paganelli, Giovanni | |
| [177 Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet? | 1-gen-2018 | Paganelli, Giovanni; De Giorgi, Ugo | |
| [18F]fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy. | 1-gen-2010 | De Giorgi, U; Amadori, D. | |
| A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity | 1-gen-2001 | Bacci, G; Ferrari, S; Tienghi, A; Bertoni, F; Mercuri, M; Longhi, A; Fiorentini, G; Forni, C; Bacchini, P; Rimondini, S; De Giorgi, U; Picci, P | |
| A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma | 1-gen-2020 | Lolli, C.; Altavilla, A.; Conteduca, V.; Farolfi, A.; Casadei, C.; Schepisi, G.; Banna, G. L.; De Giorgi, U. | |
| A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group | 1-gen-2022 | Bartoletti, M.; Bergamini, A.; Giannone, G.; Nero, C.; Musacchio, L.; Farolfi, A.; Passarelli, A.; Kuhn, E.; Castaldo, D.; Lombardo, V.; Di Palma, T.; Lorusso, D.; Puglisi, F.; De Giorgi, U.; Valabrega, G.; Schettino, C.; Scambia, G.; Capoluongo, E.; Pignata, S. | |
| A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients | 1-gen-2012 | Eechoute, K; Fransson, Mn; Reyners, Ak; de Jong, Fa; Sparreboom, A; van der Graaf, Wt; Friberg, Le; Schiavon, G; Wiemer, Ea; Verweij, J; Loos, Wj; Mathijssen, Rh; De Giorgi, U | |
| A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer | 1-gen-2015 | Pietri, E; Andreis, D; Fabbri, F; Menna, C; Schirone, A; Kopf, B; Rocca, A; Amadori, D; De Giorgi, U | |
| A Phase II study of everolimus plus oral prednisone in patients with metastatic renal cell cancer | 1-gen-2017 | Lolli, C; Gallà, V; Schepisi, G; Barone, D; Luca Burgio, S; Maugeri, A; Vertogen, B; Amadori, D; De Giorgi, U | |
| A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization | 1-gen-2006 | Kopf, B; De Giorgi, U; Vertogen, B; Monti, G; Molinari, A; Turci, D; Dazzi, C; Leoni, M; Tienghi, A; Cariello, A; Argnani, M; Frassineti, L; Scarpi, E; Rosti, G; Marangolo, M. | |
| A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study | 1-gen-2000 | Dazzi, C; Cariello, A; Giannini, M; Del Duca, M; Giovanis, P; Fiorentini, G; Leoni, M; Rosti, G; Turci, D; Tienghi, A; Vertogen, B; Zumaglini, F; De Giorgi, U; Marangolo, M | |
| Addition of androgen receptor targeted agents to androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis | 1-gen-2022 | Maiorano, B. A.; De Giorgi, U.; Roviello, G.; Messina, C.; Altavilla, A.; Cattrini, C.; Mennitto, A.; Maiello, E.; Di Maio, M. | |
| Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey | 1-gen-2016 | Diminutto, A; Basso, U; Maruzzo, M; Morelli, F; De Giorgi, U; Perin, A; Fraccon, Ap; Lo Re, G; Rizzi, A; Sava, T; Fornarini, G; Valcamonico, F; Zustovich, F; Massari, F; Zanardi, E; Roma, A; Zattoni, F; Zagonel, V | |
| Adjuvant concomitant chemotherapy in pancreatic cancer. | 1-gen-1999 | Turci, D; Cariello, A; De Giorgi, U | |
| Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: Results from the Italian national registry | 1-gen-2014 | Pedrazzoli, P; Martinelli, G; Gianni, Am; Da Prada, Ga; Ballestrero, A; Rosti, G; Frassineti, Gl; Aieta, M; Secondino, S; Cinieri, S; Fedele, R; Bengala, C; Bregni, M; Grasso, D; De Giorgi, U; Lanza, F; Castagna, L; Bruno, B; Martino, M | |
| Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry | 1-gen-2014 | Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ballestrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare |